NR4A1 and breast cancer: Hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 (HER2)-negative breast cancer represents the largest subtype of breast cancer, accounting for 75% of cases in the U.S., including the largest number of breast cancer deaths annually1,2.